Literature DB >> 23887202

Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.

Mihai Mititelu1, Brandon J Wong, Marie Brenner, Paul J Bryar, Lee M Jampol, Amani A Fawzi.   

Abstract

IMPORTANCE: Given the infrequent occurrence of hydroxychloroquine toxic effects, few data are available about the presenting features and long-term follow-up of patients with hydroxychloroquine retinopathy, making it difficult to surmise the clinical course of patients after cessation of drug treatment.
OBJECTIVE: To report functional and structural findings of hydroxychloroquine retinal toxic effects after drug therapy discontinuation.
DESIGN: A retrospective medical record review was performed to identify patients taking hydroxychloroquine who were screened for toxic effects from January 1, 2009, through August 31, 2012, in the eye centers of Northwestern University and the University of Southern California.
SETTING: Northwestern University Sorrel Rosin Eye Center, Chicago, Illinois, and the Doheny Eye Institute at the University of Southern California, Los Angeles. PARTICIPANTS: Seven consecutive patients diagnosed as having hydroxychloroquine retinal toxic effects. MAIN OUTCOME AND MEASURE: Retinal toxic effects.
RESULTS: Seven patients (1 man and 6 women) with a mean age of 55.9 years (age range, 25-74 years) developed retinal toxic effects after using hydroxychloroquine for a mean of 10.4 years (range, 3-19 years). Fundus examination revealed macular pigmentary changes in all 7 patients, corresponding to abnormal fundus autofluorescence (FAF). On spectral domain optical coherence tomography, there was outer retinal foveal resistance (preservation of the external limiting membrane and the photoreceptor layer) in 6 patients. After drug therapy discontinuation, 5 patients experienced outer retinal regeneration (3 subfoveally and 2 parafoveally), with associated functional visual improvement on static perimetry in 2 patients. Over time, FAF remained stable in 3 patients, whereas the remaining patients had a pattern of hypoautofluorescence that replaced areas of initial hyperautofluorescence (2 patients) and enlargement of the total area of abnormal FAF (2 patients). CONCLUSIONS AND RELEVANCE: Preservation of the external limiting membrane carries a positive prognostic value in hydroxychloroquine toxic effects because it may be associated with regeneration of the photoreceptor layer and with potential functional visual improvement on static perimetry. The patterns of abnormal FAF persist despite cessation of the medication, with enlargement of the total area of abnormal FAF being the hallmark of severe toxic effects. Relative foveal resistance in hydroxychloroquine toxic effects was supported by this case series. These findings emphasize the importance of early detection and the need for correlating clinical observations with multimodal imaging, particularly FAF and spectral domain optical coherence tomography.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887202     DOI: 10.1001/jamaophthalmol.2013.4244

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  29 in total

Review 1.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

2.  Hydroxychloroquine retinopathy: an emerging problem.

Authors:  M Latasiewicz; H Gourier; I H Yusuf; R Luqmani; S M Sharma; S M Downes
Journal:  Eye (Lond)       Date:  2017-02-10       Impact factor: 3.775

3.  A subtle case of hydroxychloroquine retinopathy: spectral domain optical coherence tomography findings.

Authors:  A C Barnes; K V Bhavsar; M L Weber; A J Witkin
Journal:  Eye (Lond)       Date:  2014-09-12       Impact factor: 3.775

4.  Hydroxychloroquine-induced retinopathy in a 57-year-old woman.

Authors:  Alex Ragan; Michael Fielden
Journal:  CMAJ       Date:  2016-07-11       Impact factor: 8.262

5.  Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.

Authors:  Rachel Shah; Joseph M Simonett; Riley J Lyons; Rajesh C Rao; Mark E Pennesi; Nieraj Jain
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

6.  Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.

Authors:  Emrah Kan; Konuralp Yakar; Mehmet Derya Demirag; Mustafa Gok
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

7.  Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.

Authors:  Ali M Allahdina; Paul F Stetson; Susan Vitale; Wai T Wong; Emily Y Chew; Fredrick L Ferris; Paul A Sieving; Catherine Cukras
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

8.  A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.

Authors:  Vivienne C Greenstein; Luz Amaro-Quireza; Evelyn S Abraham; Rithambara Ramachandran; Stephen H Tsang; Donald C Hood
Journal:  Doc Ophthalmol       Date:  2014-12-12       Impact factor: 2.379

Review 9.  Hydroxychloroquine retinopathy.

Authors:  I H Yusuf; S Sharma; R Luqmani; S M Downes
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

Review 10.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.